Bionano genomics news

SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics (NAS

Aug 30, 2023 · SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM) as an alternative to karyotyping (KT) and chromosomal microarray (CMA) for the evaluation of CRISPR-Cas9 edited human induced pluripotent stem cell (iPSC) lines in order to uncover possible pathogenic ... – Acquisition of BioDiscove ry transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics – Total revenue of $4.7 million , a 112% year-over-year total revenue increase, driven byCONTACTS. SAN DIEGO , Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-10. The effective time of the reverse stock split will be 5 p.m. ET on August 4, 2023.

Did you know?

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson... Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 Globe Newswire • 26 days ago.Get Bionano Genomics Inc (BNGO.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Bionano Genomics, Inc. +1 (858) 888-7610. [email protected]. Investor Relations: Amy Conrad. Juniper Point. +1 (858) 366-3243. [email protected]. Bionano CEO and president Dr. Erik Holmlin ...Get the latest BioNano Genomics Inc (BNGO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 15 Jan 2021 ... That is the question for those investing in Bionano Genomics (NASDAQ: BNGO). ... The news comes on top of advances in coronavirus and in the ...In the Medical Instruments & Supplies industry, which ranks 77 out of 146 industries, BioNano Genomics Inc ranks higher than 0% of stocks. BioNano Genomics …Genetic material is the medium by which instructions are transmitted from one generation of organisms to the next. In life on Earth, it takes the form of nucleotide sequences that are organized into genomes. A genome is all of the DNA conta...The market expects Bionano Genomics, Inc. (BNGO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2022.The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bionano Genomics' news ...Q2 2023 revenue was $8.7 million , which represents a 30% increase over Q2 2022 Installed base of Saphyr ® systems totaled 281 as of June 30, 2023 , which represents a 43% increase over Q2 2022 Sold 7,062 nanochannel array flowcells as of June 30, 2023 , which represents a 108% increase over the10 Jun 2022 ... Long String VANTAGE is designed to extract UHMW DNA for use in optical genome mapping. Credit: Hamilton Company. Hamilton and Bionano Genomics ...BNGO | Complete Bionano Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.NEW YORK – Bionano Genomics' Chinese original equipment manufacturing (OEM) partner, Beijing Genome Precision Technology (BGPT), has obtained reagent class I registrations from China's National Medical Products Administration (NMPA) for Bionano's DNA extraction kit and labeling products, GenomeWeb has learned. At …Nov 3, 2022 · SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BionanoBionano Genomics sees Q3 net loss widen 53% but beats on the top li 14 Okt 2021 ... 22, 2021. Source: Bionano Genomics. Related Content: Bio/Pharma News ...SAN DIEGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting with a broad range of content covering the utility of optical genome mapping (OGM) for solid tumor and hematological malignancy cancer research, including scientific … Bionano Genomics, Inc. is a life sciences instrumentation company, w BIONANO GENOMICS : Oppenheimer Adjusts Bionano Genomics' PT to $15 From $1.50, Citing Balance Sheet Expansion, Potential of $100 Genome; Outperform Rating Kept 2021: MT BIONANO GENOMICS : Roth Capital Downgrades Bionano Genomics to Neutral From Buy; Price Target is $0.75 2020 View the real-time Bionano Genomics Inc (NASDAQ BNGO) share pri

News Release Details « Back. Bionano Genomics Reports First Quarter 2022 Financial Results and Highlights Recent Business Progress. May 05, 2022 | PDF Version - 80% year-over-year revenue growth in Q1 2022 - Achieved all Q1 2022 ELEVATE! milestones - Strong balance sheet with $216.5 million in cash, cash equivalents, and …Welcome to the Bionano Second Quarter 2023 Financial Results Conference Call. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. He's joined by Chris Stewart, CFO of Bionano. After market ...Bionano Genomics SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company …Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...

For full-year 2023, Bionano reiterated its revenue guidance of $35.0 million to $38.0 million. The company’s Q2 revenues are expected to be in the range of $7.8 million to $8.3 million. In early morning trading on the Nasdaq, Bionano's shares were up about 7 percent at $.79.Forward-Looking Statements of Bionano Genomics. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Bionano Genomics sees Q3 net loss widen 53. Possible cause: At Bionano, we are committed to unlocking understanding of genome biology to advanc.

Bionano Genomics (BNGO 4.40%) Q2 2023 Earnings Call Aug 09, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day, and ...30 Des 2020 ... Bionano Genomics (BNGO) stock is on the move Wednesday with heavy trading following an update from the Nasdaq about its listing status.

Albino parakeets are those that exhibit a mutation in the color-producing portion of their genome. The gene that causes the mutation is called the ino gene. However, because there are two different basic colorations for parakeets—blue and...We believe this technology-centric view is holding us back from the answers to critical questions around the origin, diagnosis, severity and treatment of cancer and genetic disease. We believe the way to move forward is an inclusive one that reveals what other tools miss and unifies data across technologies into one view to maximize the ...Bionano Genomics Inc. Investors: Company Investigated by the Portnoy Law Firm. April 17, 2023 14:49 ET ... On this news the Company’s stock fell over 20% during intraday trading.

SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- B BioNano Genomics News & Media. Bionano Genomics, Inc. (BNGO) Presents at Stifel Healthcare Conference (Transcript) Bionano Genomics, Inc. (NASDAQ:NASDAQ:BNGO) Stifel Healthcare Conference Call November 15, 2023 1:50 PM ETCompany ParticipantsErik Holmlin - CEOConference... Nov 15, 2023. seekingalpha.com . Bionano Announces …Oct '23 Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan Oct '23 Bionano Announces Pricing of $80.0 Million Registered Offering and Concurrent Private Placement of Senior Secured Convertible Notes and Warrants Current page 1 2 9 Mar 2023 ... News Release Details. « Back. BionMar 9, 2023 · According to data from Benzinga Pro, BioNa BNGO | Complete Bionano Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 11 Jan 2023 ... Bionano Genomics (BNGO) is trending after announcing a publication showing that genome mapping can help in identifying breast cancer. SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- Bionano G A big change in the C-suite was behind the steep fall in Bionano Genomics ' ( BNGO -12.27%) share price on Monday. Following the biotech's announcement that its CFO is stepping down, investors ...Bionano’s Stratys system for OGM offers increased throughput capabilities to address the needs of mid and high-volume users. The throughput of the Stratys instrument is up to four times greater than that of Bionano’s Saphyr instrument, it is compatible with the latest G2 chemistry and has a potential sample-to-answer time of 3 days for ... SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Bionano’s Stratys system for OGM offers increaseSAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. ( Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per share a year ago. SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ A list of the latest Bionano Genomics Inc News - BNGO Stock News, Press Releases, Earnings Report, Financial Disclosures, Offerings, Acquisitions.About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. Bionano Genomics. April 24, 2023 at 9:54 AM ·[See the latest Bionano Genomics Inc stock price (BNGO:XNATrack Bionano Genomics Inc (BNGO) Stock Price, Quote, latest c In the Medical Instruments & Supplies industry, which ranks 77 out of 146 industries, BioNano Genomics Inc ranks higher than 0% of stocks. BioNano Genomics …